To test whether mutated DNA MMR genes could be implicated in an increase in number of mutations and consequently of neoantigens in ALL, we explored the mutations in MSH2, MSH6, MLH1 and PMS2. This evidence concerns the gene MSH2 and acute lymphoblastic leukemia.